Ndife B - Search Results

1

Development and testing of an alternative responder definition for EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).

Wratten S, Abetz-Webb L, Arenson E, Griffiths P, Bowman S, Hueber W, Ndife B, Kuessner D, Goswami P. Wratten S, et al. Among authors: ndife b. RMD Open. 2023 Mar;9(1):e002721. doi: 10.1136/rmdopen-2022-002721. RMD Open. 2023. PMID: 36931685 Free PMC article.

2

Content Validity of Sjögren's Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren's.

Griffiths N, Wratten S, Flynn J, Bookman AAM, Ndife B, Hueber W, Goswami P. Griffiths N, et al. Among authors: ndife b. Rheumatol Ther. 2022 Dec;9(6):1559-1574. doi: 10.1007/s40744-022-00489-y. Epub 2022 Sep 24. Rheumatol Ther. 2022. PMID: 36152275 Free PMC article.

3

Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.

Cooper C, Wratten S, Williams-Hall R, Bookman AAM, Ndife B, Hueber W, Goswami P. Cooper C, et al. Among authors: ndife b. Rheumatol Ther. 2022 Dec;9(6):1499-1515. doi: 10.1007/s40744-022-00487-0. Epub 2022 Sep 16. Rheumatol Ther. 2022. PMID: 36114443 Free PMC article.

4

Economic Burden Associated With Nasal Polyposis Recurrence Among Commercially Insured Patients in the United States.

Zhdanava M, Ndife B, Pilon D, Rossi C, Vermette-Laforme M, Lefebvre P, Suh JD. Zhdanava M, et al. Among authors: ndife b. Otolaryngol Head Neck Surg. 2023 Jan;168(1):65-73. doi: 10.1177/01945998221089187. Otolaryngol Head Neck Surg. 2023. PMID: 35349388

5

Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center.

Willis C, Menon J, Unni S, Au T, Yoo M, Biskupiak J, Brixner D, Ndife B, Joseph G, Bonifacio G, Stein E, Tantravahi S, Shami PJ, Kovacsovics T, Stenehjem D. Willis C, et al. Among authors: ndife b. Leuk Res. 2019 Dec;87:106262. doi: 10.1016/j.leukres.2019.106262. Epub 2019 Oct 24. Leuk Res. 2019. PMID: 31756575

6

Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer Perspective.

Stellato D, Gerbasi ME, Ndife B, Ghate SR, Moynahan A, Mishra D, Gunda P, Koruth R, Delea TE. Stellato D, et al. Among authors: ndife b. J Manag Care Spec Pharm. 2019 Nov;25(11):1227-1237. doi: 10.18553/jmcp.2019.25.11.1227. J Manag Care Spec Pharm. 2019. PMID: 31663466 Free PMC article.

7

Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective.

Gerbasi ME, Stellato D, Ghate SR, Ndife B, Moynahan A, Mishra D, Gunda P, Koruth R, Delea TE. Gerbasi ME, et al. Among authors: ndife b. J Med Econ. 2019 Dec;22(12):1243-1252. doi: 10.1080/13696998.2019.1635487. Epub 2019 Aug 4. J Med Econ. 2019. PMID: 31223037 Free article.

8

Targeted agents or immuno-oncology therapies as first-line therapy for BRAF-mutated metastatic melanoma: a real-world study.

Luke JJ, Ghate SR, Kish J, Lee CH, McAllister L, Mehta S, Ndife B, Feinberg BA. Luke JJ, et al. Among authors: ndife b. Future Oncol. 2019 Sep 1;15(25):2933-2942. doi: 10.2217/fon-2018-0964. Epub 2019 Feb 25. Future Oncol. 2019. PMID: 30799646 Free article. Clinical Trial.

9

Patient preferences for treatment of metastatic melanoma.

Mansfield C, Ndife B, Chen J, Gallaher K, Ghate S. Mansfield C, et al. Among authors: ndife b. Future Oncol. 2019 Apr;15(11):1255-1268. doi: 10.2217/fon-2018-0871. Epub 2019 Jan 29. Future Oncol. 2019. PMID: 30694080 Free article.

10

Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective.

Ritchie EK, Latremouille-Viau D, Guerin A, Pivneva I, Habucky K, Ndife B, Joseph GJ, Atallah EL. Ritchie EK, et al. Among authors: ndife b. Leuk Lymphoma. 2019 Jun;60(6):1476-1484. doi: 10.1080/10428194.2018.1538510. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters